A flexible modeling and inference framework for estimating variant effect sizes from GWAS summary statistics DOI Creative Commons
Jeffrey P. Spence, Nasa Sinnott-Armstrong, Themistocles L. Assimes

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2022, Volume and Issue: unknown

Published: April 19, 2022

Abstract Genome-wide association studies (GWAS) have highlighted that almost any trait is affected by many variants of relatively small effect. On one hand this presents a challenge for inferring the effect single variant as signal-to-noise ratio high This compounded when combining information across in polygenic scores predicting values. other hand, large number contributing provides an opportunity to learn about average behavior encoded distribution sizes. Many approaches looked at aspects problem, but no method has unified inference effects individual with sizes while requiring only GWAS summary statistics and properly accounting linkage disequilibrium between variants. Here we present flexible, unifying framework combines infer uses improve estimation We also develop variational (VI) scheme perform efficient under framework. show useful constructing (PGSs) outperform state-of-the-art. Our modeling easily extends jointly multiple cohorts, where building PGSs using additional cohorts differing ancestries improves predictive accuracy portability. investigate inferred distributions traits find these ranging over orders magnitude, contrast assumptions implicit commonly-used statistical genetics methods.

Language: Английский

A saturated map of common genetic variants associated with human height DOI Creative Commons
Loïc Yengo, Sailaja Vedantam, Eirini Marouli

et al.

Nature, Journal Year: 2022, Volume and Issue: 610(7933), P. 704 - 712

Published: Oct. 12, 2022

Common single-nucleotide polymorphisms (SNPs) are predicted to collectively explain 40-50% of phenotypic variation in human height, but identifying the specific variants and associated regions requires huge sample sizes

Language: Английский

Citations

490

Pharmacogenomics: current status and future perspectives DOI
Munir Pirmohamed

Nature Reviews Genetics, Journal Year: 2023, Volume and Issue: 24(6), P. 350 - 362

Published: Jan. 27, 2023

Language: Английский

Citations

163

Polygenic scoring accuracy varies across the genetic ancestry continuum DOI Creative Commons
Yi Ding, Kangcheng Hou,

Ziqi Xu

et al.

Nature, Journal Year: 2023, Volume and Issue: 618(7966), P. 774 - 781

Published: May 17, 2023

Abstract Polygenic scores (PGSs) have limited portability across different groupings of individuals (for example, by genetic ancestries and/or social determinants health), preventing their equitable use 1–3 . PGS has typically been assessed using a single aggregate population-level statistic R 2 ) 4 , ignoring inter-individual variation within the population. Here, large and diverse Los Angeles biobank 5 (ATLAS, n = 36,778) along with UK Biobank 6 (UKBB, 487,409), we show that accuracy decreases individual-to-individual continuum 7 in all considered populations, even traditionally labelled ‘homogeneous’ ancestries. The decreasing trend is well captured continuous measure distance (GD) from training data: Pearson correlation −0.95 between GD averaged 84 traits. When applying models trained on as white British UKBB to European ATLAS, furthest decile 14% lower relative closest decile; notably, Hispanic Latino American similar performance significantly correlated estimates themselves for 82 traits, further emphasizing importance incorporating interpretation. Our results highlight need move away discrete ancestry clusters towards when considering PGSs.

Language: Английский

Citations

156

Validation of biomarkers of aging DOI
Mahdi Moqri, Chiara Herzog, Jesse R. Poganik

et al.

Nature Medicine, Journal Year: 2024, Volume and Issue: 30(2), P. 360 - 372

Published: Feb. 1, 2024

Language: Английский

Citations

106

Challenges and Opportunities for Developing More Generalizable Polygenic Risk Scores DOI
Ying Wang, Kristin Tsuo, Masahiro Kanai

et al.

Annual Review of Biomedical Data Science, Journal Year: 2022, Volume and Issue: 5(1), P. 293 - 320

Published: May 16, 2022

Polygenic risk scores (PRS) estimate an individual's genetic likelihood of complex traits and diseases by aggregating information across multiple variants identified from genome-wide association studies. PRS can predict a broad spectrum have therefore been widely used in research settings. Some work has investigated their potential applications as biomarkers preventative medicine, but significant is still needed to definitively establish communicate absolute patients for modifiable factors demographic groups. However, the biggest limitation currently that they show poor generalizability diverse ancestries cohorts. Major efforts are underway through methodological development data generation initiatives improve generalizability. This review aims comprehensively discuss current progress on PRS, affect generalizability, promising areas improving accuracy, portability, implementation.

Language: Английский

Citations

100

Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations DOI Creative Commons
Niall J. Lennon, Leah C. Kottyan, Christopher Kachulis

et al.

Nature Medicine, Journal Year: 2024, Volume and Issue: 30(2), P. 480 - 487

Published: Feb. 1, 2024

Polygenic risk scores (PRSs) have improved in predictive performance, but several challenges remain to be addressed before PRSs can implemented the clinic, including reduced performance of diverse populations, and interpretation communication genetic results both providers patients. To address these challenges, National Human Genome Research Institute-funded Electronic Medical Records Genomics (eMERGE) Network has developed a framework pipeline for return PRS-based genome-informed assessment 25,000 adults children as part clinical study. From an initial list 23 conditions, ten were selected implementation based on PRS medical actionability potential utility, cardiometabolic diseases cancer. Standardized metrics considered selection process, with additional consideration given strength evidence African Hispanic populations. We then (score transfer laboratory, validation verification score performance), used ancestry calibrate mean variance, utilizing genetically data from 13,475 participants All Us Program cohort train test model parameters. Finally, we created regulatory compliance report inclusion assessment. The experience eMERGE inform approach needed implement testing settings.

Language: Английский

Citations

77

Leveraging base-pair mammalian constraint to understand genetic variation and human disease DOI
Patrick F. Sullivan, Jennifer R. S. Meadows, Steven Gazal

et al.

Science, Journal Year: 2023, Volume and Issue: 380(6643)

Published: April 27, 2023

Thousands of genomic regions have been associated with heritable human diseases, but attempts to elucidate biological mechanisms are impeded by an inability discern which positions functionally important. Evolutionary constraint is a powerful predictor function, agnostic cell type or disease mechanism. Single-base phyloP scores from 240 mammals identified 3.3% the genome as significantly constrained and likely functional. We compared annotation, association studies, copy-number variation, clinical genetics findings, cancer data. Constrained enriched for variants that explain common heritability more than other functional annotations. Our results improve variant annotation also highlight regulatory landscape still needs be further explored linked disease.

Language: Английский

Citations

69

Amplification is the primary mode of gene-by-sex interaction in complex human traits DOI Creative Commons

Carrie Zhu,

Matthew J. Ming,

Jared M. Cole

et al.

Cell Genomics, Journal Year: 2023, Volume and Issue: 3(5), P. 100297 - 100297

Published: April 6, 2023

Sex differences in complex traits are suspected to be part due widespread gene-by-sex interactions (GxSex), but empirical evidence has been elusive. Here, we infer the mixture of ways which polygenic effects on physiological covary between males and females. We find that GxSex is pervasive acts primarily through systematic sex magnitude many genetic ("amplification") rather than identity causal variants. Amplification patterns account for trait variance. In some cases, testosterone may mediate amplification. Finally, develop a population-genetic test linking contemporary natural selection sexually antagonistic variants affecting levels. Our results suggest amplification common mode contribute fuel their evolution.

Language: Английский

Citations

64

The Singapore National Precision Medicine Strategy DOI
Eleanor Wong, Nicolas Bertin, Maxime Hebrard

et al.

Nature Genetics, Journal Year: 2023, Volume and Issue: 55(2), P. 178 - 186

Published: Jan. 19, 2023

Language: Английский

Citations

49

Calibrated prediction intervals for polygenic scores across diverse contexts DOI
Kangcheng Hou,

Ziqi Xu,

Yi Ding

et al.

Nature Genetics, Journal Year: 2024, Volume and Issue: 56(7), P. 1386 - 1396

Published: June 17, 2024

Language: Английский

Citations

21